The FDA announced on 2018-08-15 that Hetero Labs Limited is recalling Montelukast Sodium Tablets 10 mg due to a labeling mix-up hazard. The agency said one lot may contain Losartan Potassium instead of the labeled drug. Owners should contact the company for a full refund.
How to tell if you have it
- Brand: Hetero Labs
- Product: Montelukast Sodium Tablets 10 mg, 30-count bottle
- NDC: 31722-726-30
- Lot #: MON17384
- Expiration Date: 12/19
- Manufacturer: Hetero Labs Limited, Unit V
- Distributed to: U.S.A. Nationwide
- Units affected: 98016 bottles
The hazard
The FDA said one lot labeled Montelukast Sodium Tablets 10 mg may contain 90 tablets of Losartan Potassium 50 mg instead. This labeling error creates a risk of patients receiving the wrong medication. The recall is classified as Class I, the most serious category.
Context
GovInfoNow's records show Hetero Labs Limited (Unit V) has had six other recalls since 2017-12-22. Recent issues include a 2026-03-26 recall for Pantoprazole Tablets due to discoloration and a 2020-08-06 recall of Losartan Tablets involving bulging tablets. Other recent recalls of similar products include Sun Pharmaceutical Perampanel 6mg Tablets Recall: Label Mix-Up Risk (2026-06-17), Alvogen Thyro-Tabs 150mcg Tablets Recall: Product Mix-Up Risk (2025-12-31), and Annora Pharma Lacosamide Tablets Recall: Possible Selexipag Mix-Up (2026-06-04).